173 related articles for article (PubMed ID: 15926190)
1. Programmed disorders of beta-cell development and function as one cause for type 2 diabetes? The GK rat paradigm.
Portha B
Diabetes Metab Res Rev; 2005; 21(6):495-504. PubMed ID: 15926190
[TBL] [Abstract][Full Text] [Related]
2. The GK rat beta-cell: a prototype for the diseased human beta-cell in type 2 diabetes?
Portha B; Lacraz G; Kergoat M; Homo-Delarche F; Giroix MH; Bailbé D; Gangnerau MN; Dolz M; Tourrel-Cuzin C; Movassat J
Mol Cell Endocrinol; 2009 Jan; 297(1-2):73-85. PubMed ID: 18640239
[TBL] [Abstract][Full Text] [Related]
3. Type 2 diabetes - a matter of failing beta-cell neogenesis? Clues from the GK rat model.
Movassat J; Calderari S; Fernández E; Martín MA; Escrivá F; Plachot C; Gangnerau MN; Serradas P; Alvarez C; Portha B
Diabetes Obes Metab; 2007 Nov; 9 Suppl 2():187-95. PubMed ID: 17919193
[TBL] [Abstract][Full Text] [Related]
4. Is defective pancreatic beta-cell mass environmentally programmed in Goto-Kakizaki rat model of type 2 diabetes?: insights from crossbreeding studies during suckling period.
Calderari S; Gangnerau MN; Meile MJ; Portha B; Serradas P
Pancreas; 2006 Nov; 33(4):412-7. PubMed ID: 17079948
[TBL] [Abstract][Full Text] [Related]
5. Impaired beta-cell regeneration after partial pancreatectomy in the adult Goto-Kakizaki rat, a spontaneous model of type II diabetes.
Plachot C; Movassat J; Portha B
Histochem Cell Biol; 2001 Aug; 116(2):131-9. PubMed ID: 11685541
[TBL] [Abstract][Full Text] [Related]
6. Beta-cell function and mass in type 2 diabetes.
Larsen MO
Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
[TBL] [Abstract][Full Text] [Related]
7. The GK rat: a prototype for the study of non-overweight type 2 diabetes.
Portha B; Giroix MH; Tourrel-Cuzin C; Le-Stunff H; Movassat J
Methods Mol Biol; 2012; 933():125-59. PubMed ID: 22893405
[TBL] [Abstract][Full Text] [Related]
8. [Morphological changes of islet of Langerhans in an animal model of type 2 diabetes].
Seiça RM; Martins MJ; Pessa PB; Santos RM; Rosário LM; Suzuki KI; Martins MI
Acta Med Port; 2003; 16(6):381-8. PubMed ID: 15631848
[TBL] [Abstract][Full Text] [Related]
9. Defective functional β-cell mass and Type 2 diabetes in the Goto-Kakizaki rat model.
Portha B; Lacraz G; Dolz M; Homo-Delarche F; Giroix MH; Movassat J
Expert Rev Endocrinol Metab; 2007 Nov; 2(6):785-795. PubMed ID: 30290473
[TBL] [Abstract][Full Text] [Related]
10. [Transmitted beta-cell dysfunction as a cause for type 2-diabetes].
Portha B
Med Sci (Paris); 2003; 19(8-9):847-53. PubMed ID: 14593616
[TBL] [Abstract][Full Text] [Related]
11. Goto-Kakizaki rats: its suitability as non-obese diabetic animal model for spontaneous type 2 diabetes mellitus.
Akash MS; Rehman K; Chen S
Curr Diabetes Rev; 2013 Sep; 9(5):387-96. PubMed ID: 23855509
[TBL] [Abstract][Full Text] [Related]
12. Anatomical versus functional beta-cell mass in experimental diabetes.
Kargar C; Ktorza A
Diabetes Obes Metab; 2008 Nov; 10 Suppl 4():43-53. PubMed ID: 18834432
[TBL] [Abstract][Full Text] [Related]
13. Undernutrition of the GK rat during gestation improves pancreatic IGF-2 and beta-cell mass in the fetuses.
Fernández-Millán E; Gangnerau MN; De Miguel-Santos L; Calderari S; Serradas P; Escrivá F; Portha B; Alvarez C
Growth Factors; 2009 Dec; 27(6):409-18. PubMed ID: 19919529
[TBL] [Abstract][Full Text] [Related]
14. Assessing progression to impaired glucose tolerance and type 2 diabetes mellitus.
Guerrero-Romero F; Rodríguez-Morán M
Eur J Clin Invest; 2006 Nov; 36(11):796-802. PubMed ID: 17032347
[TBL] [Abstract][Full Text] [Related]
15. How the hindgut can cure type 2 diabetes. Ileal transposition improves glucose metabolism and beta-cell function in Goto-kakizaki rats through an enhanced Proglucagon gene expression and L-cell number.
Patriti A; Aisa MC; Annetti C; Sidoni A; Galli F; Ferri I; Gullà N; Donini A
Surgery; 2007 Jul; 142(1):74-85. PubMed ID: 17630003
[TBL] [Abstract][Full Text] [Related]
16. Circadian and age-dependent expression patterns of GLUT2 and glucokinase in the pancreatic beta-cell of diabetic and nondiabetic rats.
Frese T; Bazwinsky I; Mühlbauer E; Peschke E
Horm Metab Res; 2007 Aug; 39(8):567-74. PubMed ID: 17712721
[TBL] [Abstract][Full Text] [Related]
17. Beta-cell apoptosis in type 2 diabetes: quantitative and functional consequences.
Lupi R; Del Prato S
Diabetes Metab; 2008 Feb; 34 Suppl 2():S56-64. PubMed ID: 18640587
[TBL] [Abstract][Full Text] [Related]
18. Fate of the beta-cell in the pathophysiology of type 2 diabetes.
Campbell RK
J Am Pharm Assoc (2003); 2009; 49 Suppl 1():S10-5. PubMed ID: 19801360
[TBL] [Abstract][Full Text] [Related]
19. The quest for a model of type II diabetes with nephropathy: the Goto Kakizaki rat.
Janssen U; Vassiliadou A; Riley SG; Phillips AO; Floege J
J Nephrol; 2004; 17(6):769-73. PubMed ID: 15593049
[TBL] [Abstract][Full Text] [Related]
20. Protection of pancreatic beta-cells: is it feasible?
Bonora E
Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):74-83. PubMed ID: 18096375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
